Accuray Incorporated is a premier radiation oncology company develops and manufactures health-care products such as CyberKnife and TomoTherapy Systems to deliver radiation therapy. The company is traded on the NASDAQ and has roughly 600 installed base systems in 33 countries worldwide [13]. Stock was bought at 11:43am, slightly after the MACD line crossed the signal line and zero line, indicating an upward trend. 2,500 shares were purchased at $7.34 for a total of $18,350.00. At 3:07pm, the price appeared to have peaked and started going downward. The stock was sold for $7.51 a share, yielding a profit of $405.00.